{
  "company_info": {
    "name": "Corrected Multi-Service Medispa Analysis",
    "location": "Undisclosed Location",
    "ttm_window": "2024-Q1 â†’ 2024-Q4"
  },
  "ttm_metrics": {
    "ttm_revenue": 3726100,
    "ttm_ebitda_reported": 1567000,
    "ttm_ebitda_adjusted": 1699000,
    "ttm_margin": 0.456
  },
  "ebitda_bridge": {
    "reported_ebitda": 1567000,
    "owner_addback": 300000,
    "marketing_normalization": -484000,
    "interest_reclassification": 195000,
    "repairs_normalization": 120000,
    "adjusted_ebitda": 1699000
  },
  "valuation_matrix": [
    {
      "multiple": 4.5,
      "enterprise_value": 7645500,
      "equity_value_to_seller": 5495500,
      "ev_revenue_ratio": 2.05
    },
    {
      "multiple": 5.0,
      "enterprise_value": 8495000,
      "equity_value_to_seller": 6345000,
      "ev_revenue_ratio": 2.28
    },
    {
      "multiple": 5.5,
      "enterprise_value": 9344500,
      "equity_value_to_seller": 7194500,
      "ev_revenue_ratio": 2.51
    },
    {
      "multiple": 6.0,
      "enterprise_value": 10194000,
      "equity_value_to_seller": 8044000,
      "ev_revenue_ratio": 2.74
    },
    {
      "multiple": 6.5,
      "enterprise_value": 11043500,
      "equity_value_to_seller": 8893500,
      "ev_revenue_ratio": 2.96
    }
  ],
  "epv_analysis": {
    "fcf_year_1": 1358400,
    "fcf_year_2": 1440000,
    "fcf_year_3": 1527000,
    "terminal_value": 15270000,
    "total_pv": 6134000,
    "wacc": 0.125,
    "terminal_growth": 0.025,
    "epv_enterprise": 6134000,
    "epv_equity": 3984000,
    "epv_multiple": 3.6
  },
  "lbo_analysis": {
    "purchase_price": 9344500,
    "debt": 6100000,
    "sponsor_equity": 3244500,
    "exit_ev": 11800000,
    "exit_debt": 4270000,
    "exit_equity": 7530000,
    "irr": 0.234,
    "moic": 2.32,
    "years": 4
  },
  "sensitivity_analysis": {
    "revenue_growth_cases": [
      { "growth": -0.05, "ebitda": 1529000, "ev": 8409500, "irr": 0.08 },
      { "growth": 0.0, "ebitda": 1699000, "ev": 9344500, "irr": 0.15 },
      { "growth": 0.06, "ebitda": 1801000, "ev": 9905500, "irr": 0.23 },
      { "growth": 0.12, "ebitda": 1902000, "ev": 10465500, "irr": 0.31 }
    ],
    "multiple_cases": [
      { "multiple": 4.5, "ev": 7645500, "irr": 0.12 },
      { "multiple": 5.5, "ev": 9344500, "irr": 0.23 },
      { "multiple": 6.5, "ev": 11043500, "irr": 0.34 }
    ]
  },
  "kpi_dashboard": {
    "revenue_growth": 0.06,
    "ebitda_margin": 0.456,
    "return_on_equity": 0.234,
    "debt_to_ebitda": 1.26,
    "cash_conversion": 0.85,
    "customer_retention": 0.92
  },
  "monte_carlo": {
    "iterations": 10000,
    "mean_irr": 0.138,
    "median_irr": 0.14,
    "std_irr": 0.08,
    "percentile_10": -0.002,
    "percentile_90": 0.277,
    "prob_positive": 0.895,
    "prob_above_15": 0.467,
    "prob_above_20": 0.293
  },
  "scenario_analysis": {
    "bear": {
      "probability": 0.25,
      "revenue_growth": -0.05,
      "ebitda_margin": 0.38,
      "exit_multiple": 4.5,
      "irr": 0.08
    },
    "base": {
      "probability": 0.5,
      "revenue_growth": 0.06,
      "ebitda_margin": 0.456,
      "exit_multiple": 5.5,
      "irr": 0.15
    },
    "bull": {
      "probability": 0.25,
      "revenue_growth": 0.12,
      "ebitda_margin": 0.5,
      "exit_multiple": 6.5,
      "irr": 0.31
    }
  },
  "tornado_chart": [
    {
      "factor": "Exit Multiple",
      "low_irr": 0.12,
      "high_irr": 0.34,
      "impact": 0.22
    },
    {
      "factor": "EBITDA Margin",
      "low_irr": 0.08,
      "high_irr": 0.31,
      "impact": 0.23
    },
    {
      "factor": "Revenue Growth",
      "low_irr": 0.08,
      "high_irr": 0.31,
      "impact": 0.23
    },
    {
      "factor": "Purchase Multiple",
      "low_irr": 0.18,
      "high_irr": 0.28,
      "impact": 0.1
    },
    {
      "factor": "Debt Level",
      "low_irr": 0.2,
      "high_irr": 0.26,
      "impact": 0.06
    },
    {
      "factor": "Hold Period",
      "low_irr": 0.21,
      "high_irr": 0.25,
      "impact": 0.04
    }
  ],
  "debt_structure": {
    "senior_debt": 2150000,
    "working_capital": 50000,
    "cash": 25000,
    "net_debt": 2175000
  },
  "service_lines": [
    {
      "name": "Energy Devices",
      "revenue": 245800,
      "margin": 0.91,
      "growth": -0.12
    },
    {
      "name": "Injectables",
      "revenue": 930000,
      "margin": 0.6,
      "growth": -0.09
    },
    { "name": "Wellness", "revenue": 763800, "margin": 0.75, "growth": 0.35 },
    { "name": "Weightloss", "revenue": 718400, "margin": 0.64, "growth": 0.16 },
    {
      "name": "Retail Sales",
      "revenue": 335000,
      "margin": 0.53,
      "growth": 0.04
    },
    { "name": "Surgery", "revenue": 733100, "margin": 0.89, "growth": 0.19 }
  ],
  "adjustments_explanation": {
    "marketing": "Normalized from $37K (1% of revenue) to $521K (14% industry standard) - Critical adjustment",
    "interest": "Reclassified $195K from operating expenses to financing costs - Proper EBITDA treatment",
    "repairs": "Normalized $120K for 2022 maintenance spike above run-rate - One-time adjustment",
    "owner_comp": "Added back $300K excess owner compensation above market rate - Standard practice"
  },
  "investment_highlights": [
    "Exceptional 70.4% gross margins",
    "Diversified 6-service portfolio",
    "Strong operational leverage demonstrated",
    "Growth in high-margin services (wellness +35%, surgery +19%)",
    "Corrected EBITDA validates STRONG BUY thesis"
  ]
}
